Zobrazeno 1 - 10
of 22
pro vyhledávání: '"A. K. Ryabko"'
Autor:
V. V. Firstova, A. S. Kartseva, M. V. Silkina, M. A. Marin, Ia. O. Muntian, A. K. Ryabko, I. G. Shemyakin
Publikováno v:
Инфекция и иммунитет, Vol 9, Iss 3-4, Pp 495-503 (2019)
Currently, live anthrax vaccine has been used for vaccine prophylaxis in Russia and neighbor countries for seve ral decades, but precise mechanism of post-vaccination protection mechanism remains unclear. Here, we provide data on examining serum anti
Externí odkaz:
https://doaj.org/article/2f65465c0b2849d3b5eff8ad2193e61e
Autor:
I. V. Bakhteeva, T. B. Kravchenko, A. K. Ryabko, G. M. Titareva, I. O. Lev, A. N. Mokrievich, V. S. Timofeev
Publikováno v:
Инфекция и иммунитет, Vol 8, Iss 1, Pp 33-42 (2018)
Small Gram-negative bacteria Francisella tularensis is the tularemia causative agent. This species subdivides on four subspecies — ssp. tularensis, holarctica, mediasiatica and novicida, which have some differences in their distribution areas, path
Externí odkaz:
https://doaj.org/article/847466e7666d4746a9e455a92f570570
Autor:
N. A. Zeninskaya, A. K. Ryabko, M. A. Maryin, A. S. Pinchuk, Ia. O. Muntian, V. V. Firstova, I. G. Shemyakin
Publikováno v:
Инфекция и иммунитет, Vol 8, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/25cbb511269b459ab1ca790da40e988d
Autor:
L. A. Lisitskaya, A. V. Kolesnikov, A. V. Kozyr, I. G. Shemyakin, A. K. Ryabko, O. N. Krasavtseva, LA. .. Dyatlov
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 4, Pp 115-124 (2016)
Vaccination is a key element in prophylaxis of infectious diseases. Effective vaccines based on polysaccharide capsules were developed for a number of microorganisms. Effectiveness of polysaccharides as antigens, however, is low in the main risk grou
Externí odkaz:
https://doaj.org/article/01ab761ce462443bba2f6ae4a29ba0a7
Autor:
A. V. Kolesnikov, A. V. Kozyr, L. G. Shemyakin, LA. .. Lisitskaya, M. A. Marin, A. K. Ryabko, LA. .. Dyatlov
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 4, Pp 105-115 (2016)
For many decades, live vaccines remain the most effective means for prophylaxis of bacterial infections. Until recently, the main source of vaccine strains were empirically selected bacteria, virulence of which was attenuated due to natural mutations
Externí odkaz:
https://doaj.org/article/6ca312a936f14264aa2e0ce11cc44335
Autor:
Ia. O. Muntian, M. A. Maryin, A. K. Ryabko, N. A. Zeninskaya, A. S. Pinchuk, M. V. Silkina, V. V. Firstova, I. G. Shemyakin
Publikováno v:
Инфекция и иммунитет, Vol 8, Iss 4, Pp 598-599 (2018)
Externí odkaz:
https://doaj.org/article/5d61a0bf78bb4b388646f9ec6e592452
Autor:
Natalia A. Zeninskaya, Alena K. Ryabko, Maksim A. Marin, Tatyana I. Kombarova, Maria A. Shkuratova, Methun M. Rogozin, Marina V. Silkina, Yana O. Romanenko, Tatiana A. Ivashchenko, Igor G. Shemyakin, Victoria V. Firstova
Publikováno v:
Toxins, Vol 16, Iss 7, p 284 (2024)
Botulism is one of the most serious food intoxications, manifesting as prolonged paralytic conditions. This disease is usually the result of the consumption of poor quality canned or smoked foods, so the inhabitants of many countries of the world are
Externí odkaz:
https://doaj.org/article/83da68579a3f429d9fa70d7c5c8fa5eb
Autor:
Yana O. Romanenko, Marina V. Silkina, Alena S. Kartseva, Maksim A. Marin, Maria A. Shkuratova, Maria A. Makarova, Alena K. Ryabko, Daria A. Konyshkova, Natalia A. Zeninskaya, Anna E. Khlyntseva, Igor G. Shemyakin, Victoria V. Firstova
Publikováno v:
Acta Naturae. 15:81-86
The new coronavirus infection COVID-19 is an acute viral disease that affects primarily the upper respiratory tract. The etiological agent of COVID-19 is the SARS-CoV-2 RNA virus (Coronaviridae family, Betacoronavirus genus, Sarbecovirus subgenus). W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e710b45384467729891b1a9226731e3e
https://doi.org/10.32607/actanaturae.11849
https://doi.org/10.32607/actanaturae.11849
Autor:
M. V. Silkina, A. S. Kartseva, A. K. Ryabko, M. A. Marin, Ya. O. Romanenko, O. V. Kalmantaeva, A. E. Khlyntseva, I. G. Shemyakin, I. A. Dyatlov, V. V. Firstova
Publikováno v:
Applied Biochemistry and Microbiology. 58:984-991
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f95c7f72a93d9dffdad5236021c08cd7
https://doi.org/10.1134/s0003683822090095
https://doi.org/10.1134/s0003683822090095
Autor:
I.G. Shemyakin, O.V. Kalmantaeva, Ya.O. Romanenko, A.S. Kartseva, M.A. Marin, V.V. Firstova, I.A. Dyatlov, A. K. Ryabko, A.E. Khlyntseva
Publikováno v:
Biotekhnologiya. 37:65-75
Monoclonal antibodies are an established treatment for many diseases, including cancer, toxic conditions and infectious diseases. The goal of this work was to optimize the conditions for obtaining hybridomas secreting human monoclonal IgG antibodies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9af5f89bd9d4f26bfa051976cf738a7
https://doi.org/10.21519/0234-2758-2021-37-2-65-75
https://doi.org/10.21519/0234-2758-2021-37-2-65-75